Health In Tech, Inc. (HIT) Company Overview

What does Health In Tech do?

Health In Tech, Inc. (Nasdaq: HIT) is a U.S. InsurTech company that helps employers access self-funded health plans and stop-loss coverage for unusually large claims. It reports one consolidated operating segment but earns revenue through Stone Mountain Risk (SMR), International Captive Exchange (ICE), and HI Card. HIT is not a health insurer and does not retain plan or underwriting risk. Instead, its marketplace connects employers, brokers, third-party administrators, managing general underwriters, carriers, vendors, and provider networks. The company describes the model on its official investor-relations overview.

Where does the platform sit in the insurance value chain?

Small and midsize employers can struggle with fragmented plan design, underwriting, stop-loss placement, administration, networks, and reporting. Health In Tech's eDIYBS workflow combines these steps and, for smaller groups with complete data, can produce a bindable proposal in about two minutes versus the roughly twelve days to three months the company associates with manual processes. Complex groups may still take longer.

How does Health In Tech make money?

Health In Tech is a fee-based platform. Employers buy SMR and HI Card services; carriers buy ICE underwriting support. Brokers generally do not pay HIT; they distribute plans to employer clients. Growth therefore depends on activating brokers, agencies, TPAs, and carriers that can repeatedly submit cases, rather than building a large direct-sales force.

Which revenue stream matters most?

The detailed mix and accounting appear in the company’s 2025 Form 10-K. Adding administration raises revenue per case and partner stickiness, but also increases third-party service and distribution costs, making the model less purely software-like.

What does the first quarter of 2026 show?

The quarter ended March 31, 2026 showed modest growth and a sharp profitability reset. Revenue rose 9.4% to $8.8M, but cost of revenue grew faster than sales. Management funded sales, product development, carrier expansion, and administration ahead of expected second-half revenue. The official Q1 2026 earnings release therefore presents both a growth signal and an execution test.

Why did margins contract?

Strategic turning points behind the current platform

Health In Tech is newly public but combines operating businesses with longer histories. The relevant history is how underwriting, program services, network access, and software were consolidated into one marketplace.

1. 2013
   International Captive Exchange was established. This created the managing-general-underwriter capability that still applies carrier guidelines and supports stop-loss quoting.
2. 2014
   Stone Mountain Risk was established. SMR became the program-services engine and now generates most company revenue.
3. 2017
   HI Card was formed. It added claims-data, network, and member-access ambitions, although development was later paused to concentrate resources.
4. 2021
   Health In Tech was incorporated in Nevada. The three businesses were placed under one corporate structure, enabling a consolidated platform strategy.
5. 2022
   ICE merged with DIYBS. The combination strengthened the eDIYBS digital underwriting and quoting workflow.
6. 2024
   HIT completed its IPO. The December 24 offering sold 2.3M Class A shares at $4.00 and raised $9.2M gross, financing public-company infrastructure and product expansion.
7. 2025
   Large-employer capability and channel expansion accelerated. Revenue rose 71%, software investment reached $3.5M, and billed enrolled employees increased 23% to 22,515.
8. 2026
   The model moved toward managed, end-to-end administration. More than 100 pre-designed plans, new workflow features, a $7M gross PIPE, and a planned rate-stabilization product increased both opportunity and execution complexity.

What did the 2026 product shift change?

The January 2026 launch of end-to-end self-funded administration moved HIT closer to the transaction. In Q1, the new fee generated $4.5M, or 50.8% of revenue. It may increase revenue per plan and partner stickiness, but adds vendor, working-capital, distribution, and service-quality exposure. Management described 2026 as an investment year rather than a repeat of 2025 margins.

What gives Health In Tech a competitive advantage?

HIT's potential moat is workflow integration rather than balance-sheet scale. The company competes with much larger health-benefit organizations, including UnitedHealth Group, Cigna, CVS Health, Elevance Health, and Humana, but it does not try to match their risk-bearing capacity. It aims to be faster and easier for brokers, applying carrier rules inside a digital marketplace while leaving insured claims exposure with carriers and plan sponsors.

Which resources may be difficult to replicate?

A defensible moat would emerge if brokers treat eDIYBS as their default renewal infrastructure, carriers value its underwriting pipeline, and proprietary case data improves conversion and plan design. That is plausible but not yet proven at incumbent scale. The May 2026 investor presentation emphasizes the integrated marketplace; future filings must show whether that integration produces retention, expanding placed value, and durable margins.

How financially strong is Health In Tech?

At March 31, 2026, HIT had $29.0M of assets, $7.4M of liabilities, $21.6M of equity, and $10.3M of cash. Current assets covered current liabilities about 3.1 times. The company reported no conventional funded debt beyond modest lease liabilities, but the liquidity increase came from equity issuance while operations consumed cash.

How well does accounting profit convert into cash?

FY2025 net income was $1.3M and adjusted EBITDA was $4.1M, but nearly all $3.1M of operating cash flow was reinvested in software. Q1 2026 used $3.3M of operating cash plus $0.4M for development. The balance sheet can fund near-term expansion; sustained value depends on converting that investment into positive free cash flow.

Who controls HIT, and why does it matter?

Health In Tech has a dual-class structure. Each Class A share carries one vote, while each Class B share carries ten votes and can convert into one Class A share. The latest proxy ownership table, dated September 8, 2025, showed founder and CEO Tim Johnson with 69.19% of total voting power and CFO Julia Qian with 21.83%. Directors and executive officers as a group held 91.74% of voting power. Economic ownership and voting control therefore differ substantially.

What does controlled-company status change?

The 2025 proxy statement also reported that all directors except Johnson and Qian were independent under Nasdaq standards at that date. Current biographies on the management page show additions in technology, growth, cybersecurity, and legal leadership during late 2025 and 2026. These hires fit the scale-up plan, but the founder-controlled structure means evaluation should focus heavily on execution discipline and transparent disclosure.

Distribution, carriers, and new products define the growth path

Growth depends on four linked levers: more active brokers and TPAs, more carrier partners, higher revenue per plan, and deeper workflow integration. Reiterated 2026 guidance of $45M to $50M implies 35% to 50% growth from FY2025. Because Q1 growth was only 9.4%, contracted revenue and new pipeline must convert more strongly in the remaining quarters.

Which operating KPIs matter most now?

Where can operating leverage come from?

Six in-house sales professionals supported FY2025 revenue because they recruit distribution partners rather than sell to every employer. Repeat submissions, broader carrier choice, and more than 100 pre-configured plans can create operating leverage. The constraint is that distribution and vendor costs may scale with revenue.

What risks could change the outlook?

HIT does not bear medical claims, but it remains exposed to partner concentration, revenue estimates, sensitive health data, carrier economics, talent, technology change, intellectual property, cybersecurity, privacy rules, and public-company costs.

Which risks are most company-specific?

• Carrier concentration: one stop-loss carrier represented 27.3% of FY2025 gross revenue and 47.1% of year-end accounts receivable.
• Variable consideration: FY2025 included $3.9M of estimated contra-revenue related to a carrier adjustment, with an $0.9M refund liability at year-end before final reconciliation.
• Third-party AI and data reliance: one AI data provider represented 4.2% of Q1 2026 cost of revenue, while the platform processes sensitive medical and personal information.
• Controlled-company governance: concentrated voting power may reduce external checks on capital allocation, compensation, dilution, or strategic pivots.
• Small public-company burden: FY2025 general and administrative expense reached $13.7M, including about $3.0M of incremental public-company costs.

Monitor these risks through margins, receivables, provider and carrier concentration, security disclosures, share issuance, and governance changes. The board and committee information adds oversight context; the filings supply the measurable evidence.

What is the key takeaway for a DCF analysis?

HIT is a founder-controlled marketplace digitizing self-funded employer health plans. Carriers and employers bear claims risk; HIT earns fees from underwriting workflow, plan assembly, administration, and platform services. The central tension is whether service-intensive expansion and higher technology and distribution spending can produce durable cash flow.

Which assumptions drive intrinsic value?

The company entered the Russell Microcap Index on June 29, 2026, according to its official announcement. Inclusion may increase visibility, but it does not change the DCF questions: growth quality, margin structure, reinvestment efficiency, dilution, governance, and sustainable free cash flow.